Evidence gaps and potential roles of intermittent fasting in the prevention of chronic diseases

Xiao Tong Teong, Leonie K. Heilbronn

Research output: Contribution to journalArticlepeer-review


Moderate calorie restriction (CR) has long been recognized to reduce the risk of chronic diseases that are associated with obesity and aging. Intermittent fasting (IF) has recently emerged as a viable alternative to daily CR to reduce risk markers of chronic diseases, such as type 2 diabetes and cardiovascular diseases. The majority of trials have shown that IF provides similar metabolic and weight benefits to CR, although a few suggest that IF maybe superior to CR. The type of fasting protocol that is employed varies widely and could underpin the divergence in study outcomes. This review will discuss the findings of currently available IF versus CR trials, the protocol differences that exist between studies, as well as the gaps that still exist in the field, and finally will highlight upcoming studies that will further our understanding of the metabolic effectiveness of IF diets for metabolic health.

Original languageEnglish
Article number111506
JournalExperimental Gerontology
Publication statusPublished or Issued - 1 Oct 2021
Externally publishedYes


  • Calorie restriction
  • Cardiovascular diseases
  • Intermittent fasting
  • Lifestyle intervention
  • Type 2 diabetes

ASJC Scopus subject areas

  • Biochemistry
  • Ageing
  • Molecular Biology
  • Genetics
  • Endocrinology
  • Cell Biology

Cite this